comprehensive -WSS

comprehensive

author：entertainment 2025-08-04 12:32:03 - browse：8861

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Chronically ill young patients struggle to find fertility info

Wikipedia

WSS

Chronically ill young patients struggle to find fertility info

U.K. sequencing study surfaces new findings about tumor DNA

3 trends to watch in health tech's hiring outlook for 2024

Why psychiatrists like me stop taking insurance

Goldman Sachs launches $650M fund for life science investments

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

entertainment

comprehensive

focus

Continuity nursing helped my family in our darkest PICU moments

The FDA must approve intranasal treatments for anaphylaxis

Duchenne breakthrough therapy leaves behind pioneering families

Study: Pain burden is higher in Black NFL players than white ones

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Apple is now the first public company to be valued at $3 trillion

How the political right came to back psychedelics to treat trauma

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

NIH fellows want a pay raise. Will that mean less money for grants?

leisure time

Living with Fabry disease, a condition that causes chronic pain

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

How the political right came to back psychedelics to treat trauma

Biden launches a new push to limit health care costs

New research casts further doubt on a common procedure used with IVF

It's time to get medical device identifiers over the finish line

Wikipedia

hotspot

focus

hotspot